Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2005, Vol. 105, No. 2, pp. 576-583.
Prepublished online as a Blood First Edition Paper on September 2, 2004; DOI 10.1182/blood-2004-04-1467.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-04-1467v1
105/2/576    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chute, J. P
Right arrow Articles by Oxford, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chute, J. P
Right arrow Articles by Oxford, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 20, 2004
Accepted August 23, 2004

Soluble factors elaborated by human brain endothelial cells induce the concomitant expansion of purified human BM CD34+CD38- cells and SCID repopulating cells

John P Chute*, Garrett G Muramoto, Jennifer Fung, and Carol Oxford

Stem Cell Biology Laboratory, Large Scale Biology Corporation, Vacaville, CA, USA; Division of Hematology/Oncology, UC Davis Cancer Center, Sacramento, CA, USA
Stem Cell Biology Laboratory, Large Scale Biology Corporation, Vacaville, CA, USA
The Jackson Laboratories, Sacramento, CA, USA
Department of Pathology, UC Davis, Davis, CA, USA

* Corresponding author; email: john.chute{at}duke.edu.

The CD34+CD38- phenotype identifies a population in the bone marrow that is enriched in the steady state for hematopoietic stem cells (HSC). Following ex vivo culture of CD34+ cells, HSC content is difficult to measure since committed CD34+CD38+ progenitors down regulate CD38 surface expression during culture. In this study, we sought to define the phenotype of human HSC following ex vivo culture under conditions which support the expansion of primitive SCID-repopulating cells (SRC). Contact co-culture of FACS-sorted BM CD34+CD38- cells with human brain endothelial cells (HUBEC) supported a 4.4-fold increase in CD34+CD38- cells with a concordant 3.6-fold increase in SRC over 7 days. Non-contact HUBEC cultures and the addition of thrombopoietin, SCF, and Flt-3 ligand supported further increases in CD34+CD38- cells (6.4-fold and 13.1-fold) which correlated with significant increases in SRC activity. Moreover, cell sorting studies performed on HUBEC-cultured populations demonstrated that SRC were significantly enriched within the CD34+CD38- subset as compared to the CD34-CD38- population post-culture. These results indicate that human HSC can be identified and characterized by phenotype following expansion culture. These studies also demonstrate that HUBEC-elaborated soluble factors mediate a unique and potent expansion of human HSC.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. B. Salter, S. K. Meadows, G. G. Muramoto, H. Himburg, P. Doan, P. Daher, L. Russell, B. Chen, N. J. Chao, and J. P. Chute
Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo
Blood, February 26, 2009; 113(9): 2104 - 2107.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Safi, G. G. Muramoto, A. B. Salter, S. Meadows, H. Himburg, L. Russell, P. Daher, P. Doan, M. D. Leibowitz, N. J. Chao, et al.
Pharmacological Manipulation of the RAR/RXR Signaling Pathway Maintains the Repopulating Capacity of Hematopoietic Stem Cells in Culture
Mol. Endocrinol., February 1, 2009; 23(2): 188 - 201.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. P. Chute, G. G. Muramoto, A. B. Salter, S. K. Meadows, D. W. Rickman, B. Chen, H. A. Himburg, and N. J. Chao
Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice
Blood, March 15, 2007; 109(6): 2365 - 2372.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. P. Chute, G. G. Muramoto, J. Whitesides, M. Colvin, R. Safi, N. J. Chao, and D. P. McDonnell
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells
PNAS, August 1, 2006; 103(31): 11707 - 11712.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
N. Takebe, X. Cheng, A. M. Farese, E. Welty, B. Meisenberg, and T. MacVittie
Human Brain Endothelial Cells (HUBEC) Can Expand Both Human Bone Marrow and Cord Blood SCID-Repopulating Cells (SRC) through Cell Contact Rather Than Soluble Factors.
Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 36 - 36.
[Abstract]


Home page
BloodHome page
R. B. Walter, J. L. Pirga, M. R. Cronk, S. Mayer, F. R. Appelbaum, and D. E. Banker
PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism
Blood, November 15, 2005; 106(10): 3584 - 3593.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020